Loading...
Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer
The optimal neoadjuvant chemotherapy (NACT) regimen in triple-negative breast cancer (TNBC) has not been clearly defined. Achieving a pathologic complete response (pCR) provides important prognostic information, and, especially in TNBC, is considered a surrogate endpoint for event-free survival. Thu...
Na minha lista:
| Udgivet i: | J Target Ther Cancer |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5865448/ https://ncbi.nlm.nih.gov/pubmed/29577076 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|